Scientific Program
*It is based on the local time of Seoul, Korea (UTC/ GMT +9:00) Updated as of September 7
November 15 (Wed)
Educational Session 1- Spatial genomics and computational histopathology
Date & Time | 11/15(Wed) 13:00 – 14:40 | Place | Sapphire Ballroom (3F) |
---|
- ·
-
Computational histopathology and AI enabled diagnostics: Where are we today and future directions
Anil V. Parwani (The Ohio State University Wexner Medical Center, Columbus, Ohio, USA)
- ·
-
Technical advances in spatial transcriptomics and single nucleus RNA seq by Fixative eXchange (FX)-seq for clinical FFPE cancer samples
Chang Ho Sohn (Yonsei University Advanced Science Institute, Korea)
- ·
-
The emerging landscape of single-cell and spatial multi-omics
Melanie Spears (Ontario Institute for Cancer Research, Toronto, Ontario, Canada)
- ·
-
Navigating the spatial genomics landscape: A look into the current status
Jungmin Choi (Korea University College of Medicine, Korea)
Educational Session 2- New insights of precancerous to cancerous path
Date & Time | 11/15 (Wed) 15:00 – 16:40 | Place | Sapphire Ballroom (3F) |
---|
- ·
-
Evolutionary therapy
Alexander R.A. Anderson (Moffitt Cancer Center, Tampa, Florida, USA)
- ·
-
ITF2: A potential target for suppressing colitis-associated cancer progression
Hyun-Woo Shin (Seoul National University College of Medicine, Korea)
- ·
-
Improved diagnosis of endometrial precancers
Diego H. Castrillon (UT Southwestern Medical Center, Dallas, Texas, USA)
- ·
-
Tracing cellular dynamics during intestinal tumorigenesis and tissue repair
Min Kyu Yum (Korea Advanced Institute of Science and Technology, Korea)
November 16 (Thu)
Keynote Lecture
Date & Time | 11/16 (Thu) 10:30 – 11:10 | Place | Crystal Ballroom (2F) |
---|
- ·
-
Early detection of cancer using cell-free DNA fragmentomes
Victor E. Velculescu (Johns Hopkins University School of Medicine, Baltimore, Maryland, USA)
Plenary Session 1- Precision early detection and monitoring
Date & Time | 11/16 (Thu) 08:30 – 10:10 | Place | Crystal Ballroom (2F) |
---|
- ·
-
Circulating tumor DNA analysis for detection and monitoring of lung cancer
Maximilian Diehn (Stanford University, Stanford, California, USA)
- ·
-
Cancer detection and monitoring using whole genome methylation sequencing
Duhee Bang (Yonsei University College of Science, Korea)
- ·
-
Hereditary cancer surveillance using cell-free DNA sequencing
Trevor J. Pugh (University of Toronto, Toronto, Ontario, Canada)
- ·
-
Multi cancer early detection by Exosome-SERS-AI
Yeonho Choi (Korea University School of Biomedical Engineering, Korea)
Plenary Session 2- Emerging radiation technology and radiobiology: Heavy ion therapy and FLASH
Date & Time | 11/16 (Thu) 12:30 – 14:10 | Place | Crystal Ballroom (2F) |
---|
- ·
-
Imaging and quality assurance for emerging radiation technologies: Experiences of IROC for the NCI NCTN and beyond
Michael V. Knopp (University of Cincinnati, Cincinnati, Ohio, USA)
- ·
-
Reinventing radiobiology in the light of FLASH radiotherapy
Won Il Jang (Korea Cancer Center Hospital, Korea)
- ·
-
Preclinical studies with proton FLASH radiotherapy in mouse models and canines
Constantinos Koumenis (University of Pennsylvania, Philadelphia, Pennsylvania, USA)
- ·
-
Repair of heavy ion radiation-induced complex DNA double-strand breaks
Kei-ichi Takata (Institute for Basic Science, Korea)
Plenary Session 3- Targeting tumor microenvironments in immune-oncology
Date & Time | 11/16 (Thu) 14:30 – 16:10 | Place | Crystal Ballroom (2F) |
---|
- ·
-
Metabolic vulnerabilities as therapeutic targets in ovarian cancer
Kunle Odunsi (University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, USA)
- ·
-
Tumor-associated monocytes and neutrophils: Targets for immunotherapy?
Keehoon Jung (Seoul National University College of Medicine, Korea)
- ·
-
Targeting cancer-associated fibroblasts to enhance immunotherapy: Characterising heterogeneity and exploiting plasticity
Gareth Thomas (University of Southampton, Southampton, England)
- ·
-
How is tumor immunity regulated in fibrotic gastric cancers?
Hoon Hur (Ajou University School of Medicine, Korea)
Luncheon Symposium 1 - Boryung
Date & Time | 11/16 (Thu) 11:20 – 12:00 | Place | Crystal Ballroom (2F) |
---|
- ·
-
State-of-the-art neo/adjuvant treatment in pancreatic cancer: guidance for oncologist
Hyehyun Jeong (Ulsan University College of Medicine, Korea)
Luncheon Symposium 2 - AstraZeneca
Date & Time | 11/16 (Thu) 11:20 – 11:40 | Place | Sapphire Ballroom (3F) |
---|
- ·
-
Present and future of osimertinib as the backbone therapy of EGFRm NSCLC
Min Hee Hong (Yonsei University College of Medicine, Korea)
November 17 (Fri)
Waun Ki Hong Memorial Lecture
Date & Time | 11/17 (Fri) 11:40 – 12:20 | Place | Crystal Ballroom (2F) |
---|
- ·
-
The cancer dependency map and beyond
William C. Hahn (Harvard Medical School, Boston, Massachusetts, USA)
Plenary Session 4- 2023 Cancer Progress in US and South Korea
Date & Time | 11/17 (Fri) 08:30 – 09:30 | Place | Crystal Ballroom (2F) |
---|
- ·
-
AACR Cancer Progress Report 2023
Rajarshi Sengupta (American Association for Cancer Research, Philadelphia, Pennsylvania, USA)
- ·
-
KCA Cancer Report 2023
Tae-Yong Kim (Seoul National University College of Medicine, Korea)
Plenary Session 5- Clinical trials in the precision oncology era
Date & Time | 11/17 (Fri) 09:40 – 11:20 | Place | Crystal Ballroom (2F) |
---|
- ·
-
Measuring apoptotic priming with BH3 profiling: From laboratory tool to clinical diagnostic
Anthony G. Letai (Dana-Farber Cancer Institute, Boston, Massachusetts, USA)
- ·
-
Update of K-MASTER: The first Korean precision oncology initiative
Kyong Hwa Park (Korea University College of Medicine, Korea)
- ·
-
Patient-derived tumor organoid models for functional precision medicine
Alice Soragni (University of California, Los Angeles, California, USA)
- ·
-
A pragmatic precision medicine platform: KOSMOS trial
Sun Young Kim (University of Ulsan College of Medicine, Korea)
Plenary Session 6- Aging and cancer senescence
Date & Time | 11/17 (Fri) 13:40 – 15:20 | Place | Crystal Ballroom (2F) |
---|
- ·
-
Regulation of telomerase in stem cells and cancer
Steven Artandi (Stanford Cancer Institute, Stanford, California, USA)
- ·
-
Senescent tumor cell; The novel modulator of the cancer microenvironment
Tae Jun Park (Ajou University School of Medicine, Korea)
- ·
-
Exploiting senescence to treat liver cancer
M. Celeste Simon (Abramson Family Cancer Research Institute, Philadelphia, Pennsylvania, USA)
- ·
-
The transcriptional hallmarks of oncogene-induced senescence: A combined meta-analysis and machine learning approach
Sung Young Kim (Konkuk University School of Medicine, Korea)
Plenary Session 7- Cancer plasticity and epigenetics
Date & Time | 11/17 (Fri) 15:40 – 17:20 | Place | Crystal Ballroom (2F) |
---|
- ·
-
Highly multiplexed imaging for precision breast immuno-oncology
Raza Ali (Cancer Research UK, London, England)
- ·
-
Dissecting cellular heterogeneity and plasticity of lung cancer
Jong Kyoung Kim (Pohang University of Science and Technology, Korea)
- ·
-
Understanding plasticity and histological transformation during emergence of resistance to targeted therapies
Álvaro Quintanal-Villalonga (Memorial Sloan Kettering Cancer Center, New York, New York, USA)
- ·
-
Anchorage plasticity reconstructs the metastatic cascade
Hyun Woo Park (Yonsei University College of Life Science & Biotechnology, Korea)
Luncheon Symposium 3 - MSD
Date & Time | 11/17 (Fri) 12:30 – 13:10 | Place | Crystal Ballroom (2F) |
---|
- ·
-
Pembrolizumab unveiled: Illuminating its role in esophageal, GEJ and gastric cancer as a shining star in the dark
Ho Jung An (The Catholic University of Korea, St. Vincent's Hospital, Korea)